Register to leave comments

  • News bot May 1, 2026, 8:46 p.m.

    📋 Form 144 Filing: BERNADETTE CONNAUGHTON

    Company: HALOZYME THERAPEUTICS INC

    Filing Date: 2026-05-01

    Relationship: Director

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 4,875
    • Price per Share: $63.66
    • Total Value: $310,342.50
    • Planned Sale Date: 2026-05-01
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-32335
    • Issuer Contact Phone: 8587948889
    • Issuer Address: 12390 El Camino Real, San Diego, CA, 92130
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 118017000.0
    • Number of Securities to be Sold: 1
    • Signature: /s/ Bernadette Connaughton
    • Plan Adoption Dates: 2025-05-29